These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19950301)

  • 1. Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.
    Vosters JL; Landek-Salgado MA; Yin H; Swaim WD; Kimura H; Tak PP; Caturegli P; Chiorini JA
    Arthritis Rheum; 2009 Dec; 60(12):3633-41. PubMed ID: 19950301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.
    Yin H; Cabrera-Perez J; Lai Z; Michael D; Weller M; Swaim WD; Liu X; Catalán MA; Rocha EM; Ismail N; Afione S; Rana NA; Di Pasquale G; Alevizos I; Ambudkar I; Illei GG; Chiorini JA
    Arthritis Rheum; 2013 Dec; 65(12):3228-38. PubMed ID: 23982860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.
    Yin H; Kosa P; Liu X; Swaim WD; Lai Z; Cabrera-Perez J; Di Pasquale G; Ambudkar IS; Bugge TH; Chiorini JA
    PLoS One; 2014; 9(2):e82852. PubMed ID: 24551030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans.
    Shen L; Suresh L; Li H; Zhang C; Kumar V; Pankewycz O; Ambrus JL
    Clin Immunol; 2009 Mar; 130(3):304-12. PubMed ID: 19038581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background.
    Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM
    Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland.
    Jonsson MV; Delaleu N; Brokstad KA; Berggreen E; Skarstein K
    Arthritis Rheum; 2006 Jul; 54(7):2300-5. PubMed ID: 16802370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacrimal and salivary gland inflammation in the C3H/Ipr autoimmune strain mouse: a potential mode for Sjögren's syndrome.
    Johnson BC; Morton JI; Trune DR
    Otolaryngol Head Neck Surg; 1992 Apr; 106(4):394-9. PubMed ID: 1565490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
    Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
    Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions.
    Zhou J; Jin JO; Patel ES; Yu Q
    Cytokine; 2015 Dec; 76(2):244-252. PubMed ID: 26255211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
    Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
    Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features.
    Rosas J; Ramos-Casals M; Ena J; García-Carrasco M; Verdu J; Cervera R; Font J; Caballero O; Ingelmo M; Pascual E
    Rheumatology (Oxford); 2002 Jun; 41(6):670-5. PubMed ID: 12048294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
    Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
    J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Destruction of salivary and lacrimal glands by Th1-polarized reaction in a model of secondary Sjögren's syndrome in lupus-prone female NZB × NZWF(1) mice.
    Hayashi T; Shimoyama N; Mizuno T
    Inflammation; 2012 Apr; 35(2):638-46. PubMed ID: 21786007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myd88 is required for disease development in a primary Sjögren's syndrome mouse model.
    Kiripolsky J; McCabe LG; Gaile DP; Kramer JM
    J Leukoc Biol; 2017 Dec; 102(6):1411-1420. PubMed ID: 28951424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Location of immunization and interferon-γ are central to induction of salivary gland dysfunction in Ro60 peptide immunized model of Sjögren's syndrome.
    Yin H; Vosters JL; Roescher N; D'Souza A; Kurien BT; Tak PP; Chiorini JA
    PLoS One; 2011 Mar; 6(3):e18003. PubMed ID: 21464925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response against the coiled coil domain of Sjögren's syndrome associated autoantigen Ro52 induces salivary gland dysfunction.
    Sroka M; Bagavant H; Biswas I; Ballard A; Deshmukh US
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):41-46. PubMed ID: 29465352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder.
    Gerli R; Muscat C; Giansanti M; Danieli MG; Sciuto M; Gabrielli A; Fiandra E; Vitali C
    Br J Rheumatol; 1997 Sep; 36(9):969-75. PubMed ID: 9376993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer.
    Nguyen CQ; Yin H; Lee BH; Carcamo WC; Chiorini JA; Peck AB
    Arthritis Res Ther; 2010; 12(6):R220. PubMed ID: 21182786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
    Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
    Soyfoo MS; Chivasso C; Perret J; Delporte C
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.